February 1, 2018 ― Hackensack, NJ ― Hackensack Meridian Health John Theurer Cancer Center at Hackensack University Medical Center presents the 15th Annual Northern NJ Breast Cancer Conference – a review of the 2017 San Antonio Breast Cancer Symposium, on Friday, February 23 from 7:00 a.m. - 3:15 p.m.Date
Friday, Feb. 23, 2018
7 a.m. to 3:15 p.m.Location
John Theurer Cancer Center at Hackensack University Medical Center
1st Floor Conference Room
92 Second Street, Hackensack, NJProgram Goal
This program, based on data presented at the San Antonio Breast Cancer Symposium 2017, is designed to provide a review of state of the art information on experimental biology, etiology, prevention, diagnosis and therapy of breast cancer/ pre-malignant breast disease to an audience of academic and private physicians and researchers involved in medical, surgical, GYN and radiation therapy, as well as other appropriate health care professionals.Course Director
Stanley E. Waintraub, M.D., F.A.C.P.
Breast Cancer Division Co-Chief, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJAgenda
Breast Cancer and Less Surgery
Freya Schnabel, M.D.
Professor of Surgery NYU Langone Medical Center, New York, NYRadiation Therapy:
Deciding Who Does Not Need It
Lawrence J. Solin, M.D., FACR
Chairman, Radiation Oncology, Albert Einstein Medical Center Philadelphia, PAThe Role of Neoadjuvant Therapy in Clinically Node Positive Disease
Claudine Isaacs, M.D.
Co-Director, Breast Cancer Division, MedStar Georgetown University, Washington, D.C.Metastic Breast Cancer: Anti Estrogens vs. Chemotherapy
Mary Elizabeth Cianfrocca, D.O.
Director, Breast Cancer Program, Banner MD Anderson Cancer Center Phoenix, AZThe Role of Immunotherapy in Triple Negative Breast Cancer
Adam Brufsky, M.D., Ph.D.
Professor of Medicine University of Pittsburgh, Pittsburgh, PAHormonal Adjuvant Therapy Of Breast Cancer: The Role of CDK 4/6 Inhibitors
Harold Harvey, M.D.
Professor of Medicine, Milton S. Hershey Medical Center, Hershey, PAPrecision Medicine 2018: The Role of NGS on Uncirculating Free DNA
Brian Leyland-Jones, M.D., Ph.D.
Vice President, Avera Cancer Institute for Precision Oncology University of South Dakota, Sioux Falls, SDGenomic Analysis in Early Stage Breast Cancer: Oncotype in Node Positive Breast Cancer
Andrew Seidman, M.D.
Associate Chair, Breast Medicine, Memorial Sloan Kettering Cancer Center New York, NYWho Should Attend
Medical oncologists, breast surgeons, radiation oncologists, gynecologists, advanced practice providers, nurses, and other health care providers with an interest in the management of patients with breast cancer should attend this course.Registration
To register for this event or if you have any questions, please contact Leonor Down at 551-996-5914 or Leonor.Down@hackensackmeridian.orgRegistration fee is complementary. This activity has been approved for AMA PRA Category 1 Credit™
ACCREDITATION STATEMENT: Hackensack University Medical Center is accredited by the Medical Society of New Jersey to provide continuing medical education for physicians.